Literature DB >> 12153683

Mesothelial cells: their structure, function and role in serosal repair.

Steven E Mutsaers1.   

Abstract

The mesothelium is composed of an extensive monolayer of specialized cells (mesothelial cells) that line the body's serous cavities and internal organs. Traditionally, this layer was thought to be a simple tissue with the sole function of providing a slippery, non-adhesive and protective surface to facilitate intracoelomic movement. However, with the gradual accumulation of information about serosal tissues over the years, the mesothelium is now recognized as a dynamic cellular membrane with many important functions. These include transport and movement of fluid and particulate matter across the serosal cavities, leucocyte migration in response to inflammatory mediators, synthesis of pro-inflammatory cytokines, growth factors and extracellular matrix proteins to aid in serosal repair, release of factors to promote both the deposition and clearance of fibrin, and antigen presentation. Furthermore, the secretion of molecules, such as glycosaminoglycans and lubricants, not only protects tissues from abrasion, but also from infection and possibly tumour dissemination. Mesothelium is also unlike other epithelial-like surfaces because healing appears diffusely across the denuded surface, whereas in true epithelia, healing occurs solely at the wound edges as sheets of cells. Although controversial, recent studies have begun to shed light on the mechanisms involved in mesothelial regeneration. In the present review, the current understanding of the structure and function of the mesothelium and the biology of mesothelial cells is discussed, together with recent insights into the mechanisms regulating its repair.

Entities:  

Mesh:

Year:  2002        PMID: 12153683     DOI: 10.1046/j.1440-1843.2002.00404.x

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  112 in total

1.  Lamellar Inclusions within Hyperplastic Endoplasmic Reticulum in Benign Mesothelial Cells.

Authors:  Simon Haefliger; Deepali Jain; Thomas Menter; Tatjana Vlajnic; Spasenija Savic Prince; Helmut Hopfer; Michael J Mihatsch; Lukas Bubendorf
Journal:  Acta Cytol       Date:  2020-06-29       Impact factor: 2.319

2.  Establishment of permanent cell lines purified from human mesothelioma: morphological aspects, new marker expression and karyotypic analysis.

Authors:  Marie-Marthe Philippeaux; Jean-Claude Pache; Sophie Dahoun; Marc Barnet; John-Henri Robert; Jacques Mauël; Anastase Spiliopoulos
Journal:  Histochem Cell Biol       Date:  2004-09-15       Impact factor: 4.304

3.  Identification of a novel developmental mechanism in the generation of mesothelia.

Authors:  Nichelle I Winters; Rebecca T Thomason; David M Bader
Journal:  Development       Date:  2012-07-04       Impact factor: 6.868

4.  Contribution of Myofibroblasts of Different Origins to Liver Fibrosis.

Authors:  Michel Fausther; Elise G Lavoie; Jonathan A Dranoff
Journal:  Curr Pathobiol Rep       Date:  2013-09

5.  Wt1 and β-catenin cooperatively regulate diaphragm development in the mouse.

Authors:  Nicole D Paris; Garry L Coles; Kate G Ackerman
Journal:  Dev Biol       Date:  2015-08-14       Impact factor: 3.582

6.  Electrolyte and Fluid Transport in Mesothelial Cells.

Authors:  Hong-Long Ji; Hong-Guang Nie
Journal:  J Epithel Biol Pharmacol       Date:  2008

7.  Mesothelial morphology and organisation after peritoneal treatment with solid and liquid adhesion barriers--a scanning electron microscopical study.

Authors:  Christoph Brochhausen; Volker H Schmitt; Taufiek K Rajab; Constanze N E Planck; Bernhard Krämer; Christine Tapprich; Markus Wallwiener; Helmut Hierlemann; Heinrich Planck; C James Kirkpatrick
Journal:  J Mater Sci Mater Med       Date:  2012-05-10       Impact factor: 3.896

8.  Modeling the Early Steps of Ovarian Cancer Dissemination in an Organotypic Culture of the Human Peritoneal Cavity.

Authors:  Peter C Hart; Preety Bajwa; Hilary A Kenny
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 9.  Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research.

Authors:  Emma Kipps; David S P Tan; Stan B Kaye
Journal:  Nat Rev Cancer       Date:  2013-02-21       Impact factor: 60.716

Review 10.  Gene Therapy for Alpha-1 Antitrypsin Deficiency Lung Disease.

Authors:  Maria J Chiuchiolo; Ronald G Crystal
Journal:  Ann Am Thorac Soc       Date:  2016-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.